A novel biomarker has been identified to gauge alcohol use in patients with certain health conditions. However, reports vary on the specifics of the biomarker, with some outlets mentioning different conditions and biomarkers, such as liver disease, schizophrenia, and depression. The exact nature and application of the biomarker are unclear, with multiple studies and discoveries being reported across various fields.